Multiple Myeloma Management vs SurvivorNet Usage & Stats

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
  • Apple App Store
  • Free
  • Health & Fitness

Store Rank

- -

Multiple Myeloma Management vs. SurvivorNet ranking comparison

Compare Multiple Myeloma Management ranking trend in the past 28 days vs. SurvivorNet

Rank

No Data Available

Multiple Myeloma Management vs. SurvivorNet ranking by country comparison

Compare Multiple Myeloma Management ranking trend in the past 28 days vs. SurvivorNet

No Data to Display

Compare to any site with our free trial

Get started
Multiple Myeloma Management VS.
SurvivorNet

December 19, 2024